QNCX
Quince Therapeutics, Inc.
31.20$
+7.5%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 97.7% | 99.6% | 85.3% | 72.8% | 83.8% | 90.2% | 43.0% | 38.5% | 24.5% | |
| 95.1% | 34.1% | 41.2% | 35.3% | 52.3% | 42.9% | 11.5% | 5.4% | 6.2% | |
| 95.1% | 98.4% | 80.3% | 70.6% | 80.2% | 86.8% | 41.7% | 35.6% | 19.0% | |
| – | – | – | – | 0.8% | 1.0% | 0.6% | 0.8% | 3.9% | |
| – | – | – | – | 1.7% | 2.2% | – | – | – | |
| – | 0.4% | 1.1% | 0.6% | 1.1% | 0.4% | – | – | – | |
| – | – | – | – | – | 0.0% | 9.8% | 0.0% | – | |
| – | – | – | – | – | 5.7% | 35.3% | 52.5% | 72.5% | |
| 362.8% | 2.0% | 7.1% | 9.1% | 11.0% | 3.2% | 52.8% | 73.7% | 138.2% | |
| 22.8% | 2.0% | 7.1% | 9.0% | 10.7% | 3.0% | 5.3% | 6.4% | 46.2% | |
| – | – | – | 0.1% | 0.6% | 0.4% | 0.0% | 0.1% | 19.4% | |
| 6.7% | 0.7% | 2.5% | 1.9% | 3.7% | 0.5% | 1.1% | 2.5% | 2.4% | |
| – | – | – | – | – | – | 7.5% | 12.5% | – | |
| -262.8% | 98.0% | 92.9% | 90.9% | 89.0% | 96.8% | 47.2% | 26.3% | -38.2% | |
| -263.7% | -45.0% | -56.1% | -77.4% | -177.6% | -277.4% | -177.4% | -328.9% | -492.3% | |
| 1.4% | 0.1% | 0.1% | 0.1% | 0.1% | 0.2% | 0.1% | 0.2% | 0.3% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.